Myocardial Infarction Completed Phase 4 Trials for Acetylsalicylic acid (DB00945)

Back to Myocardial Infarction

Also known as: Suspected myocardial infarction (MI) / Myocardial Infarct / MI / Myocardial Infarctions / Heart Attacks / Cardiac Infarct / Heart Attack / Myocardial Infarction (MI) / Cardiovascular Stroke / Stroke, Cardiovascular / Myocardial infarction (disorder) / Acute myocardial infarction / Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction / Attack heart (NOS) / Infarct myocardial / Right ventricular infarction / Attack coronary / Infarction of heart / Cardiac infarction, NOS / Attack - heart / Myocardial infarction, NOS / MI - myocardial infarction / Cardiac infarction / Heart attack, NOS / Infarction of heart, NOS / Myocardial infarction (& [acute]) or coronary thrombosis / Coronary artery thrombosis / Coronary artery thrombosis (disorder) / Thrombosis coronary / Coronary thrombosis / Occlusive coronary artery thrombus / Thrombosis - coronary / CT - Coronary thrombosis / (Myocardial infarction (& [acute] or [silent] or [cardiac rupture following])) or (coronary thrombosis)

Indication	Status	Phase
DBCOND0027900 (Myocardial Infarction)	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04057300	Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes	Treatment	Acetylsalicylic acid (DB00945) Clopidogrel (DB00758) Ticagrelor (DB08816)
NCT05380063	Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting	Treatment	Acetylsalicylic acid (DB00945) Ticagrelor (DB08816)
NCT02777580	STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction	Treatment	Acetylsalicylic acid (DB00945) Clopidogrel (DB00758) Tenecteplase (DB00031)
NCT02545933	Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor	Treatment	Acetylsalicylic acid (DB00945) Prasugrel (DB06209) Ticagrelor (DB08816) Vorapaxar (DB09030)
NCT00915733	Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism	Treatment	Acetylsalicylic acid (DB00945) Cilostazol (DB01166) Clopidogrel (DB00758)
NCT03207451	Vorapaxar on Thrombin Generation and Coagulability	Health Services Research	Acetylsalicylic acid (DB00945) Clopidogrel (DB00758) Vorapaxar (DB09030)
NCT02247128	Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation	Prevention	Acetylsalicylic acid (DB00945) Clopidogrel (DB00758)
NCT02548650	Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus	Treatment	Acetylsalicylic acid (DB00945) Clopidogrel (DB00758) Vorapaxar (DB09030)
NCT01559298	Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial	Prevention	Acetylsalicylic acid (DB00945) Clopidogrel (DB00758)
NCT00272337	Aspirin Dose and Atherosclerosis in Patients With Heart Disease	Treatment	Acetylsalicylic acid (DB00945)
NCT03228017	Subclinical Cardiovascular Disease in Psoriatic Disease	Treatment	Acetylsalicylic acid (DB00945) Atorvastatin (DB01076)
NCT02640794	Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI	Prevention	Acetylsalicylic acid (DB00945) Clopidogrel (DB00758)